Member Info for ogm4

As I understand currently one single syringe of glucagon costs around 300 USD offered on the market by the few existing manufacturers, which is certainly not cheap. Insurance companies take the majority of that. Let's hear what the team has to say tomorrow.

GM scheduled on 7th April 11am

P140 still main focus for IMM

Since Nov starting to engage with some new potential partners on P140

Global type 1 diabetes market size:

USD 37 billion in 2025

USD 41 billion in 2026

USD 79 billion by 2035

Indeed it is appearing now:

977,649 @ 6.82p

worth £66.70k

Thanks 86KB.

Getting a bit exciting now!...

The whole team is dedicated to securing a partnership deal that does justice to the innovation and clinical potential of P140, valuing a more methodical approach over speed, so the best outcome for shareholders can be achieved. We are seeking a partner whose culture and aspirations match those of the Board, prioritising long-term synergy.

The Company's financial position is now secure into Q4 2026 which provides the Company with the support and time to advance partnership activities. We look forward to providing further updates in due course."

"advance partnership activities..."

7.40p keeps reappearing now

400,000 possible buy @ 7.90p from yesterday worth £31k

Tick up

I can't buy at the moment, not sure why

No worries, my point is an RNS is official.

Hopefully news soon then.

I agree after months of radio silence, even if there is nothing to announce, but then at least confirm talks are still ongoing.

$60 million upfront,

$1.1 billion for milestones...

Belgium's UCB in autoimmune drug deal with Antengene

By Reuters

March 4, 20268:32 AM GMT+4Updated 4 hours ago

https://www.reuters.com/business/healthcare-pharmaceuticals/belgiums-ucb-autoimmune-drug-deal-with-antengene-2026-03-04/

You're welcome guys

Https://www.fiercebiotech.com/biotech/boehringer-pens-500m-pact-british-biotech-oral-approach-autoimmune-diseases

Wow, great find SYN00GOLD !!!....

Even the sp seemed to have stalled , now picking up pace again